Long-term follow-up of patients with papillary and follicular thyroid cancer: A prospective study on 715 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1352-1359

  Brassard, Maryse ^a   Borget, I ^a   Edet Sanson, A ^b   Giraudet, A L ^c   Mundler, O ^d   Toubeau, M ^e   Bonichon, F ^f   Borson Chazot, F ^g   Leenhardt, L ^h   Schvartz, C ⁱ   Dejax, C ^j   Brenot Rossi, I ^k   Toubert, M E ^l   Torlontano, M ^m   Benhamou, E ^a   Schlumberger, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE HENRI BECQUEREL   (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d TIMONE HOSPITAL   (France)

^e CENTRE GEORGES FRANÇOIS LECLERC   (France)

^f INSTITUT BERGONIÉ   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ INSTITUT JEAN GODINOT   (France)

^j CENTRE JEAN PERRIN   (France)

^k INSTITUT PAOLI CALMETTES   (France)

^l SAINT LOUIS HOSPITAL   (France)

^m CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR ABLATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CARCINOMA, PAPILLARY, FOLLICULAR; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955675264     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2708     Document Type: Article

References (24)

1. Cooper DS, Doherty GM, Haugen BR, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
2. Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC, Hong SJ, Shong YK 2005 Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90:1440-1445
3. Toubeau M, Touzery C, Arveux P, Chaplain G, Vaillant G, Berriolo A, Riedinger JM, Boichot C, Cochet A, Brunotte F 2004 Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988-994 (Pubitemid 47611686)
4. Hall FT, Beasley NJ, Eski SJ, Witterick IJ, Walfish PG, Freeman JL 2003 Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope 113:77-81 (Pubitemid 36050517)
5. Pelttari H, Välimäki MJ, Löyttyniemi E, Schalin-Jäntti C 2010 Postablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study. Eur J Endocrinol 163:757-763
6. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L 2011 Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? Clin Endocrinol (Oxf) 74:111-117
7. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96 (Pubitemid 36033867)
8. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human TSH-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673 (Pubitemid 37034512)
9. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzò G, Meringolo D, Feretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402-3407
10. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
11. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A 2002 Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499-1501 (Pubitemid 34615228)
12. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB 1988 Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063-1075
13. DeGroot LJ 1994 Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer. Am J Med 97:499-500 (Pubitemid 24370878)
14. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058
15. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
16. Tzavara I, Vlassopoulou B, Alevizaki C, Koukoulis G, Tzanela M, Koumoussi P, Sotsiou F, Thalassinos N 1999 Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) 50:643-654 (Pubitemid 29236342)
17. Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P 2003 Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13:949-958 (Pubitemid 37351878)
18. Spencer C, Fatemi S, Singer P, Nicoloff J, Lopresti J 2010 Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid 20:587-595
19. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlaetger MH, Claustrat F, Koscielny S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenenbaum F, Bardet S, Bussière F, Girard JJ, Morel O, Schneegans O, Schlienger JL, Prost A, So D, Archambeaud F, Ricard M, Benhamou E 2007 Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 92:2487-2495
20. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
21. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
22. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D, Morrow M eds. 2002 American Joint Committee on Cancer: AJCC cancer staging manual. 6th ed. New York: Springer
23. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111 (Pubitemid 36337763)
24. Drummond MF, Sculpher M, Torrance GW, O'Brien BJ, Stoddart GL 2005 Methods for the economic evaluation of health care programmes. 3rd ed. Oxford, UK: Oxford Medical Publications